National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

F.R.L.I.

1996B02856

STATUTORY RULES.

1964. No. Γ 7

R EG U L A TIO N S U N D E R T H E N A T IO N A L H E A LT H A C T 1953-1963.*

T T H E G O V E R N O R -G E N E R A L in and over the Commonwealth of 1, Australia, acting with the advice of the Federal Executive Council, hereby make the follow ing Regulations under the National Health Act 1953-1963.

Dated this

DE L’ JSLE

Governor-General.

By H is E xcellency’s Command,

(SGD.) H.W.WADE

Minister of State for Health.

A m e n d m e n t s o f t h e N a t io n a l H e a l t h ( P h a r m a c e u t ic a l B e n e f i t s )

R e g u l a t io n s, t

1. These Regulations shall com e in to operation on the first day of May, commence-

1964. ment·

4063/64.—P rice 2s. 6d. 10/15.4.1964.

2. Regulation. 35 o f the National Health (Pharmaceutical Benefits) standards of Regulations is amended by adding at the end thereof the follow ing sub- and'purit'yof reg u la t io n s:-

additives.

“ (7.) W here the letters ‘ B.P. 1958 ’ appear after the name of the pharmaceutical benefit or the additive, the standards of com position and purity are those constituted by the description of that pharmaceutical benefit and of its ingredients, or o f that additive, as the ease may be, in the edition o f the book called the British Pharmacopoeia published under the direction o f the General M edical Council o f the United Kingdom in the year 1958, as affected by the additions or amendments contained in the 1960 Addendum to that book.

“ (8.) W here the letters ‘ B.P.C. 1959 ’ appear after the name o f the pharmaceutical benefit or the additive, the standards o f com position and purity arc those constituted by the description o f that pharmaceutical benefit and o f its ingredients, or of that additive, as the ease may be, in the edition of the book called the British Pharmaceutical C odex published by direction o f the Council o f the Pharmaceutical Society o f Great Britain in the year 1959.”.

* Notified in the Commonwealth Gazette on "? ( D _ 1964.

t Statutory Rules I960, No. 17, as amended By Statutory'Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; and 1964, No. 12.

National Health (Pharmaceutical Benefits) Regulations. 2

3. The First, Second, Third, Fourth and Fifth Schedules to the National First, Second, Third, Fourth

Health (Pharmaceutical Benefits) Regulations are repealed and the following	and Fifth
Schedules inserted in their stead:—	Schedules.

FIRST SCHEDULE.

Regulation 10.

D rugs and M edicinal Preparations in the Uritish Pharmacopoeia that are not

TO BE SUPPLIED AS, OR EXCEPT AS SPECIALLY PROVIDED USED IN, PHARMACEUTICAL

B e n e f i t s .

Acetazolamide.	Colchicum Conn.
Acctomcnaphthone.	Colctiicum Liquid Extract.
Acetomcnaphthone Tablets.	Coriander.
Acetrizoic Acid.	Corlicotrophin.
Alcohol (95%).	Cresol and Soap Solution.
Dilute Alcohols.	Cresol.
Dehydrated Alcohol.	Crotamiton.
Almond Oil.	Cyanocobalamin.
Amcthocaine Hydrochloride.	Cyclizinc Tablets.
Ammomatcd Mercury Ointment.	Cyclobarbitone Calcium.
Amodiaquinc Hydrochloride.	Cyclomelhycaine Sulphate.
Amphetamine Sulphate.	Cyclopropane.
Amylobarbitone Sodium Tablets,	Dapsone.
Antazoline Hydrochloride.	Deoxycortone Trimethylacetate.
Antimony Potassium Tartrate.	Dequalinium Acetate.
Antimony Potassium Tartrate Injection.	Dcqualinium Chloride.
Antimony Sodium Tartrate.	Dcxamcthasonc.
Antimony Sodium Tartrate Injection.	Dcxamcthasone Acetate.
Apomorphine Hydrochloride.	Dexamphetamine Sulphate.
Apomorphine Injection.	Dextromethorphan Hydrobromide.
Bacillus Calmette-Gucrin Vaccine.	Dextromethorphan Tablets.
Bacitracin.	Diamorphine Hydrochloride.
Bcmegride.	Diamorphine Injection.
Bendrofluazide.	Dibromopropamidine Isethionate.
Benzhexol Hydrochloride.	Dichlorphenamidc.

Benztropinc Methanesu Iph onate. Diethazine Hydrochloride.

Benztropinc Tablets.	Dicthylcarbanrazine Citrate.
Botulinum Antitoxin.	Digitoxin.
Busulphan.	Diloxanide Furcate.
Butobarbitone.	Dimcnhydrinate.
Calciferol.	Dimcnhydrinate Injection.
Caramiphen Hydrochloride.	Dimenhydrinale Tablets.
Caraway.	Dimercaprol.
Carbac-hol.	Dimethisteronc.
Carbimazolc.	Dimethistcronc Tablets.
Carbon Dioxide.	Diodone Injection.
Carbromal Tablets.	Diphtheria and Pertussis Vaccine.
Cardamom Fruit.	Dipipanonc Hydrochloride.
Cascara,	Dipipanonc Injection.
Catgut, Sterilised Surgical.	Domiphen Bromide.
Cellulose, Oxidised.

Edrophonium Chloride.

Cetylpyridinium Chloride.	Emetine and Bismuth Iodide.
Chlorambucil.	Emetine Hydrochloride.
Chlorcyclizine Hydrochloride.	Ergomctrine Maleate.
Chloroquine Phosphate.	Erythromycin.
Chloroquine Sulphate.	Ethinylocstradiol.
Chlorothiazide.	Ethistcronc.
Chiorphcnesin.	Ethopropazine Hydrochloride.
Chlorpropamide.	Elliotoin.
Chorionic Gonadotrophin.	Ethyl Chloride.
Chorionic Gonadotrophin Injection.	Ethyl Olcatc.
Cinchocainc Hydrochloride.	Ethylcnodiamino Hydrate.
Cinnamon.	Eugcnol.
Citric Acid, Anhydrous.	Fludrocortisone Acetate.
Cochineal.	Fluoxymcstcrone.
Colchicine.	Gallaminc Tricthiodide.

National Health (Pharmaceutical Benefits) Regulations. 3

Gallamine Injection.	Mephcntermine Sulphate.
Gelatin Sponge, Absorbable.	Meprobamate.
Gentian.	Meprobamate Tablets.
Ginger.	Mercaptopurine.
Glutethimide.	Mcrsalyl Acid.
Griseofiulvin.	Methadone Hydrochloride.
Guanethidine Sulphate.	Methandienone.
Halothane.	Methoin.
Helium.	Methyl Hydroxybenzoate.
Heparin.	Mcthylamphctamine Hydrochloride.
Hexamethonium Tartrate.	Methyltestosteronc.
Hexamethonium Tartrate Injection.	Methyl thiouracil.
Hexylresorcinol.	Methyprylone.
Histamine Acid Phosphate.	Mcthyprylone Tablets,
Human Blood, Whole.	Mustine Hydrochloride.
Human Red Blood Corpuscles, Concen­	Nalorphine Hydrobromide.
trated. Human Fibrin Foam.	Nandrolonc Phcnylpropionate.
Naphazoline Hydrochloride.
Human Fibrinogen.	Neostigmine Bromide.
Human Gamma Globulin.	Nicotinic Acid.
Human Gamma Globulin Injection.	Nikethamide.
Human Plasma, Dried.	Nikethamide Injection.
Human Serum, Dried.	Nitrous Oxide.
Human Thrombin.	Norethisterone.
Hydrallazine Hydrochloride.	Norethisterone Tablets.
Hydrallazino Tablets.	Noscapine.
Hydrochlorothiazide.	Nux Vomica.
Hydrocortisone Ointment.	Oestradiol Benzoate.
Hydrocortisone Acetate Ointment.	Opium.
Hydrocortisone Hydrogen Succinate.	Opium, Powdered.
Hydroflumethiazide.	Orange Peel, Dried Bitter.
Hydrogen Peroxide Solution, Strong.	Orange Peel, Fresh Bitter.
Hydroxocobalamin.	Oxygen
Hydroxychloroquine Sulphate.	Oxytetracycline Dihydrate.
Hyoscine Eye Ointment.	Paramelhadionc.
Hyoscyamus.	Pempidine Tartrate.
Imipramine Hydrochloride,	Pentamidine Isethionate.
Imipramine Tablets.	Pentamidine Injection.
Indigo Carmine.	Perphenazine.
Influenza Vaccine.	Perphenazine Tablets.
lodipamide Mcthylglucamme Injection.	Pethidine Tablets.
Iodised Oil Fluid Injection.	Phanquonc.
Iodised Oil Viscous Injection.	Phanquone Tablets.
Iopanoic Acid.	Phenelzine Sulphate.
Iopanoic Acid Tablets,	Phenelzine Tablets.
lophendylate Injection.	Phcnindaminc Tablets.
Ipecacuanha, Prepared.	Phenindione.
Ipecacuanha and Opium Tablets.	Phcnolphthalein Tablets.

Isoniazid.	Phenolsulphonphthalein.
Isopropyl Alcohol.	Phcnoxybenzamine Hydrochloride.
Kaolin Poultice.	Phenoxymethylpcnicillin.
Lead Acetate,	Phentolamine Hydrochloride.
Lead Monoxide.	Phcntolamine Tablets.
Lemon Peel, Dried.	Phentolamine Methancsulphonatc.

Lignocaine Hydrochloride.

Phentolamine Injection.

Lignocaine and Adrenaline Injection.

Phenylbutazone,

Lignocaine Hydrochloride Injection.

Phytomcnadione.

Lucanthone Hydrochloride.

Phytomcnadionc Capsules.

Lucanthone Tablets.

Phytomcnadione Tablets.

Magnesium Stearate.

Picrotoxin.

Male Fern.

Piperazine Phosphate.

Maleic Acid.

Piperocaine Hydrochloride.

Poliomyelitis Vaccine (Inactivated).

Mannitol.

Poliomyelitis Vaccine (Oral).

Mecamylamine Hydrochloride.

Potassium Chloride Injection,

Melarsoprol.

Potassium Perchlorate.

Menaphthone Sodium Bisulphite.

Prednisone Acetate.

Mepacrine Hydrochloride.

Primaquine Phosphate.

National Health (Pharmaceutical Benefits) Regulations. 4

Primidone.	Solapsone Tablets.
Probenecid.	Staphylococcus Antitoxin.
Procaine and Adrenaline Injection.	Stibophen.
Prochlorperazine Maleate,	Stibophen Injection.
Prochlorperazine Tablets.	Stramonium.
Prochlorperazine Methanesulphonate.	Sulphadimidine Sodium.
Prochlorperazine Injection.	Sulphamcthizole.
Procyclidine Hydrochloride.	Sulphamelhoxypyridazine.
Proguanil Hydrochloride.	Sulphasomidine.
Promazine Hydrochloride.	Sulphasomidinc Tablets.
Promazine Injection.	Sulphobrcmophthalein Sodium.
Promazine Tablets.	Suramin.
Promethazine Theoclate.	Suramin Injection.
Promethazine Theoclate Tablets.	Suxamethonium Bromide.
Propyl Gallate.	Suxamethonium Chloride.
Propyl llydroxybenzoate.	Testosterone.
Propyliodone.	Testosterone Phenylpropionate.
Propyliodone Injection.	Testosterone Phenylpropionate Injection.
Propyliodone Oily Injection.	Tetrachioroethylenc.
Propylthiouracil.	Tctrachloroethylenc Capsules.
Pyridostigmine Bromide.	Thiambutosinc.
Pyrimethamine.	Thiomcrsal.
Quillaia.	Thiopentone Sodium.
Rabies Antiserum.	Thiopentone Injection.
Rabies Vaccine.	Thioridazine Hydrochloride.
Schick Control.	Thyroid.
Senna Leaf.	Thyroxine Sodium.
Sesame Oil.	Tolazolinc Hydrochloride.
Soda Lime.	Tolbutamide.
Sodium Acetrizoate Injection.	Trichloroethylene.
Sodium Anoxynaphthonate.	Trifluoperazine Hydrochloride.
Sodium Antimonylgiuconatc.	Tripelennamine Hydrochloride.
Sodium Antimonylgiuconatc Injection.	Tryparsamide.
Sodium Aurothiomalate.	Tryparsamidc Injection.
Sodium Bicarbonate Injection.	Tuberculin, Old.
Sodium Calciumcdetatc.	Tuberculin Purified Protein Derivative*
Sodium Chromate (r,’Cr) Injection.	Tubocurarinc Chloride.
Sodium Diatrizoate.	Tubocurarine Injection.
Sodium Diatrizoate Injection.	Typhoid-Paratyphoid A and B and Cholera

Sodium Fluoride. Vaccine.

Sodium Iodide ('’’I) Injection. Typhoid-Paratyphoid A and B and Tetanus

Sodium Iodide I) Solution. Vaccine.

Sodium Lauryl Sulphate.	Typhoid-Paratyphoid A, B, and C. Vaccine.
Sodium Phosphate C’-P) Injeclion.	Urethane.
Sodium Stibogluconate.	Vinyl Ether.
Sodium Stibogluconate Injection.	Vitamin A Ester Concentrate.
Solapsonc.	Vcilow Fever Vaccine.

SECOND SCHEDULE.

Regulation 10(3).

A llowadle Compounds ( if any) o r Certain Drugs or Medicinal Preparations.

Pharmaceutical Benefits. Allowable Compounds (if any).

Acrylic Resin. . ... . Adrenaline Acid Tartralc, 1). P.. .

Aluminium Powder, B.P.C. . . Aluminium Powder B.P.C. witli Liquid Paraffin B.P.

and Zinc Oxide Ointment B.P.

Aluminium Hydroxide Gel Dried Aluminium Hydroxide Gel Dried B.P. with Mag­

B.P. nesium Hydroxide B.P.C.

Aluminium Hydroxide Gel Dried B.P. with Mag­

nesium Trisilicatc B.P.

National Health (Pharmaceutical Benefits) Regulations. 5

Second Schedule—continued.

Pharmaceutical Benefits. Allowable Compounds (if any).

Aluminium Hydroxide Gel Dried B.P. with Mag­ nesium Carbonate B.P.

Aluminium Hydroxide Gel Dried B.P. with Mag­ nesium Trisilicate B.P. and Magnesium Hydroxide B.P.C.

Dihydrostreptomycin Sulphate B.P. 1958 with Atta­ pulgite, Pectin and Aluminium Hydroxide Gel Dried B.P.

Prednisolone B.P. with Magnesium Trisilicate B.P.

and Dried Aluminium Hydroxide Gel B.P.

Prednisone B.P. with Magnesium Trisilicate B.P. and

Dried Aluminium Hydroxide Gel B.P.

Amphotericin B. .. Tetracycline with a buffering agent and Amphotericin

B.

Anourino Hydrochloride, B.P. Vitamin A with Alienrinc Hydrochloride B.P., Ribo- flavinc B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D.

Antazolinc Sulphate	..	Antazolinc Sulphate with Naphazolinc Nitrate B.P.
Ascorbic Acid, B.P.	..	Vitamin A with Anemine Hydrochloride B.P., Ribo- flavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D

Attapulgite .. .. .. Dihydrostrcptomycin Sulphate B.P. 1958 with Atta­ pulgite, Pectin and Hydrated Alumina Powder B.P.

Bacitracin Hye Drops .. ..

Benzol (Commercial) .. .. Betamethasone Disodium Phos­

phate

Betamethasone Phosphate	..
Calciferol Solution, B.P.	..

Calcium Lactobionale	..	..	Thcnalidinc with Calcium Lactobionatc
Carbromal, B.P.	..	. .	Carbromal B.P., with Pentobarbitone Sodium B.P.
Chloramine, B.P.C.	..	..
Chloramphenicol, B.P. ..	. .	Chloramphenicol B.P. with Polymyxin B. Sulphate

B.P.

Chlorhexidine Gluconate ..

Chlorpheniramine Malcate, B.P. ..

Chlorpromazine Hydrochloride, B.P.

Chlortetiacyclinc Hydrochloride, B.P.

Clemizolc Tan mile	..	..
Cortisone Acetate, B.P.	..

Cymogran. . .. .. Cyproheptadine Hydrochloride ..

Cyclizinc Hydrochloride, B.P. .. Ergotamine Tartrate B.P. with Caffeine B.P, and

Cyclizinc Hydrochloride B.P.

Dcmccarium Bromide .. .. Demcthylchlortetracycline Hydro­

chloride, B.P, Dexchlorpheniramme Maleatc ..

Dextran .. .. .. Dextran with Dextrose B.P. Dextran in Normal Saline

Dicyclomine Hydrochloride, B.P.C. Dienocstrol, B.P.. . ..

Digoxin, B.P. .. .. ..

Dihydrostreptomycin Sulphate, B.P. Dihydroslroptomycin Sulphate B.P. 1958 with At- lapulgitc, Pectin and Hydrated Alumina Powder B.P.

1958

Dihydrotachystcrol .. ,.

Diphenhydramine Hydrochloride, Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C.

B.P. 1959 and Diphenhydramine Hydrochloride B.P.

Diphtheria Vaccine, B.P. .. Diphtheria and Tetanus Vaccine B.P. Diphtheria, Tetanus and Pertussis Vaccine B.P.

Dyflos, B.P.C. .. ., ..

National Health (Pharmaceutical Benefits) Regulations. 6

Second Schedule—continued.

Pharmaceutical Benefits. Allowable Compounds (if any).

Ecothiopatc Iodide ..

Entsufon .. .. Hexachlorophanc B.P. with Entsufon.

Ergotamine Tartrate, B.P.

Ergotamine Tartrate B.P. with Caffeine B.P.

Ergotamine Tartrate B.P. with Caffeine B.P. and

Cyclizino Hydrochloride B.P.

Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C.

1959 and Diphenhydramine Hydrochloride B.P.

Ergotamine Tartrate B.P. witli Caffeine B.P. and

Mcclozinc Hydrochloride B.P.

Erythromycin Oral Suspensions

Ethosuximidc. .	,.
Ferric Hydroxide	..

Ferrous Aminoacetosulphate

Ferrous Gluconate, B.P.

Ferrous Succinate	..
Framycetin Sulphate	..

Galactomin .. ..

Glucose Indicator ..

Gramicidin .. .. Polymyxin B. Sulphate B.P. with Neomycin Sulphate

B.P. and Gramicidin

Hamamelis Dry Extract, B.P.C.	Hamamelis Dry Extract B.P.C. with Zinc Oxide, B.P.
Hexachlorophanc, B.P. ..	Hexachlorophanc B.P. with Entsufon Hexachlorophanc B.P. with Lissapol Hexachlorophanc B.P. in Soap Solution

Hydrocortisone, B.P. ..

Hydrocortisone Acetate, B.P. Hydrocortisone Acetate B.P. with Neomycin Sulphate

B.P.

Ipecacuanha, B.P. Phcnolphthalein B.P. with Aloin B.P.C., Dry Extract of Belladonna B.P., Strychnine B.P.C. 1959 and Ipecacuanha B.P.

Isoprcnaline Hydrochloride	..
Levallorphan Tartrate, B.P.	. . Levallorphan Tartrate B.P. with Pethidine Hydro­

chloride B.P.

Lissapol .. .. .. Lissapol with Spearmint Oil B.P.C. and Cclrimide B.P. Hexachlorophanc B.P. with Lissapol

Lofenalac .. .. .. Magnesium Bicarbonate Solution,

B.P. 1948

Magnesium Chloride

Ammonium Chloride B.P. with Sodium Chloride B.P.,

Potassium Chloride B.P. and Magnesium Chloride

Sodium Lactate with Potassium Chloride B.P., Mag­

nesium Chloride and Sodium Chloride B.P.

Mcbhydrolin Napadisylate, B.P.C.

Mcclozino Hydrochloride, B.P. .. Ergotamine Tartrate B.P. with Caffeine B.P. and

Mcclozinc Hydrochloride B.P.

Mepyraminc Maleatc, B.P. .. Mercuric Oxide Eye Ointment,

B.P.C. Metlulilazine Hydrochloride ..

Methyl Glucaminc .. .. Theophylline B.P. with Methyl Glucaminc

Minafcn .. .. .,

Naphazoline Nitrate, B.P.	..	Naphazoline Nitrate B.P. with Antazolinc Sulphate
Neomycin Sulphate ,B.P.	..	Hydrocortisone Acetate B.P. with Neomycin Sulphate

B.P.

Polymyxin B. Sulphate B.P. with Bacitracin B.P. and

Neomycin Sulphate B.P.

Neomycin Sulphate B.P. with Kaolin B.P.

Polymyxin B. Sulphate B.P. with Neomycin Sulphate

B.P. and Gramicidin

Neostigmine Methylsulphatc B.P. —

Nicotinamide, B.P. ., .. Vitamin A with Ancurino Hydrochloride B.P., Riho- flavinc B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D

National Health (Pharmaceutical Benefits) Regulations. 7

Second Schedule-- continued.

Pharmaceutical Benefit1 ;. Allowable Compounds (if any).

Nitrofurantoin, B.P.	..	..
Nystatin, B.P.. .	..	.. Tetracycline with a buffering agent and Nystatin B.P.
Oleandomycin	..	. . Tetracycline with Oleandomycin

Oxytctracyclmc Hydrochloride, B.P. Oxytctracyclmc Hydrochloride B.P. with Polymyxin B.

Sulphate B.P.

Oxytocin .. .. .. Pancrcatin Enzyme U.S.N.F. XI. .

Papaveretum, B.P.C.	..	..	Papaveretum B.P.C. with Hyoscinc Hydrobromide B.P.
Paracetamol, B.P.	..	..

Penicillin, Bonethaminc, B.P.C. .. Penicillin, Benethamine B.P.C. with Procaine Peni­ cillin B.P, and Sodium Penicillin B.P.

Penicillin, Benzathine, B.P. .. Penicillin, Benzathine B.P. with Procaine Penicillin

B.P. and Potassium Penicillin B.P.

Penicillin, Benzyl, B.P. .. . . Penicillin, Benzyl B.P. with Streptomycin Sulphate B.P. Fortified Procaine Penicillin Injection B.P. Penicillin, Benzyl B.P. with Procaine Penicillin B.P.

and Streptomycin Sulphate B.P.

Penicillin, Phcnoxymolhyl (Benza­ thine, Calcium, Ilydrabaminc or Potassium Salt or Free Acid)

Penicillin, Potassium, B.P.	..	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Penicillin, Procaine, B.P.	..	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Fortified Procaine Penicillin Injection B.P. Penicillin, Benethamine B.P.C. with Procaine Peni­

cillin B.P. and Sodium Penicillin B.P.

Penicillin, Benzyl B.P. with Procaine Penicillin B.P.

and Streptomycin Sulphate B.P.

Penicillin, Sodium, B.P...	Penicillin, Benethamine B.P. with Procaine Penicillin and Sodium Penicillin B.P.
Pentolinium Tartrate, B.P.	Pentolinium Tartrate B.P. with Ephcdrinc Hydro­ chloride B.P.
Pertussis Vaccine, B.P.. .	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Pethidine Hydrochloride, B.P.	Pethidine Hydrochloride B.P. with Lcvallorphan Tartrate B.P.
Pethidine Hydrochloride B.P. with Scopolamine Hydrobromidc B.P.

Pheniramine Matoate, B.P, ..

Phenytoi n. .. .. ..

Pipcnzolato Methobromido ..

Piperazine Citrate, B.P.. .. . Pituitary (Posterior Lobe), Pow­

dered, B.P.C.

Polymyxin B. Sulphate, B.P. .. Chloramphenicol B.P. with Polymyxin B. Sulphate

B.P.

Oxytctracyclmc Hydrochloride B.P. with Polymyxin B. Sulphate B.P.

Polymyxin B. Sulphate B.P. with Bacitracin B.P. and

Neomycin Sulphate B.P.

Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin

Polymyxin B. Sulphate with Propylene Glycol and Acetic Acid

Prednisolone, B.P. .. .. Prednisolone B.P. with Magnesium Trisilicalc B.P.

and Dried Aluminium Hydroxide Gel B.P.

Mcthylprcdnisolone, B.P. ..

Prednisolone Sodium Phosphate,

B.P.C.

Prednisolone Trimethylacetate,

B.P.

Prednisone, B.P. .. .. Prednisone B.P. with Magnesium Trisilicate B.P. and

Dried Aluminium Hydroxide Gel B.P.

National Health (Pharmaceutical Benefits) Regulations. 8

Second Schedule—continued.

Pharmaceutical Benefits. Allowable Compounds (if any).

Promethazine Hydrochloride, B.P.

Riboflavine, B.P. .. .. Vitamin A with Ancurinc Hydrochloride B.P., Ribo- flavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D.

Senna Fruit, B.P. ,. .. Silver Nitrate, Toughened, B.P. .. Sobee .. .. ..

Sodium Lactate .. .. Sodium Lactate with Potassium Chloride B.P. and

Sodium Chloride B.P.

Sodium Lactate with Potassium Chloride B.P., Mag­ nesium Chloride and Sodium Chloride B.P.

Sodium Lactate with Sodium Chloride B.P. and

Dextrose B.P.

Sodium Lactate with Sodium Chloride B.P.

Sodium Lactate with Potassium Chloride B.P. and

Dextrose B.P.

Sodium Potassium Tartrate B.P.C.	Compound Effervescent Powder, B.P.C.
Sodium Tauroglycocholate B.P.C.	Sodium Tauroglycocholate B.P.C. 1954 with Cascara

1954 Dry Lxtract B.P.

Spearmint Oil, B.P.C.	..	..	Lissapol with Spearmint Oil B.P.C. and Cetrimidc B.P.
Sulphacctamidc, B.P.C.. .	..	Sulphacctamidc B.P.C. with Sulphamerazinc B.P.

1958 and Sulphadiazine B.P.

Sulphadimethoxinc, B.P.C. ..

Sulphafurazole, B.P. .. ..

Sulphamcrazinc, B.P. 1958 .. Sulphamcrazine B.P. 1958 with Sulphadiazine B.P.

and Sulphathiazole B.P.C.

Sulphamcrazine B.P. 1958 with Sulphadiazine B.P.

and Sulphacctamidc B.P.C.

Sulphamcrazine B.P. 1958 with Sulphadiazine B.P.

and Sulphadimidine B.P.

Sulphamethoxydiazine. . .. Sulphamcthoxypyridazine N-Acetyl

Sulphaphenazole, B.P.C. ..

Sulphathiazole, B.P.C.	..	..	Sulphathiazole B.P.C. with Sulphamcrazine B.P. 1958 and Sulphadiazine B.P.
Surgical Cement	..	..

Tacrine .. .. ., Morphine Sulphate B.P. with Tacrine

Tetanus Vaccine, B.P. .. . . Diphtheria and Tetanus Vaccine B.P. Diphtheria, Tetanus and Pertussis Vaccine B.P.

Tetracycline Hydrochloride, B.P. .. Tetracycline Hydrochloride B.P. with a buffering agent

Tetracycline .. .. .. Tetracycline with a buffering agent and Amphotericin

B.

Tetracycline with a buffering agent and Nystatin B.P.

Tetracycline with Oleandomycin

Thenalidine .. .. . Thenalidine with Calcium Lactobionate

Thenalidine Tartrate .. . Thenalidine Tartrate with Calcium Lactate B.P. and

Calcium Gluconate B.P.

Theobromine, B.P.C. ..	.	Theobromine B.P.C. with Plienobarbitone B.P.
Tragacanth (Gum Karaya)	.
Trimeprazine Tartrate, B.P.C.. Triprolidine Hydrochloride, B.P.C Velactin. . .. .
Viomycin Pantothenate ..	.	Viomycin Sulphate B.P. with Viomycin Pantothenate
Viomycin Sulphate, B.P.	.	Viomycin Sulphate B.P. with Viomycin Pantothenate
Viprynium Lmbonatc ..	.

Vitamin A .. .. . Vitamins A and D Concentrated Solution Vitamin A with Aneurine Hydrochloride B.P., Ribo-

flavine B.P., Nicotinamide B.P., Ascorbic Acid B.P.

and Vitamin D

Vitamin D

Vitamins A and D Concentrated Solution

Vitamin A with Aneurine Hydrochloride Β.Γ., Ribo­

flavine B.P., Nicotinamide B.P., Ascorbic Acid B.P.

and Vitamin D

National Health (Pharmaceutical Benefits) Regulations. 9

THIRD SCHEDULE.

Regulation 11.

D rugs and M edicinal Preparations Additional to the Drugs and M edicinal

Preparations in h ie British Pharmacopoeia.

Acetarsol Dicthylamine.	Caffeine Citrate, B.P.C. 1959.
Acetazolamidc Sodium.	Cajuput Spirit, B.P. 1948.
Acetic Acid, Glacial, U.P.C.	Calamine Cream, A.P.F.
Acetohexamide.	Calcium Aurothiomalatc.
Acidified Golden Syrup, A.P.F.	Calcium Di-Oxytctracyclinc.

Acrid avine,	B.P.C.	Calcium Gluconogalactogluconatc.
Acrylic Resin.	Calcium Laclobionatc.

Adrenaline Hydrochloride.	Calcium Phosphate, B.P.C.
Adrenaline Mucate.	Calumba, Concentrated Infusion, B.P.

Agar B.P.C. 1954. 1948.

Alkavcrvir.	Calumba Tincture, B.P. 1948.
Aloin B.P.C.	Capsicum Ointment, B.P.C.
Almond Oil Volatile Bitter, B.P.C. 1959	Capsicum Oleuresin, B.P.C.
Aloxidone.	Capsicum Tincture, B.P.C.
Aluminium Acetate Solution, B.P.C.	Carbarsonc, B.P.C.
Aluminium Sodium Polyhydroxy Mono­	Carbinoxamine Malcate.

carbonate Ilcxitol Complex. Cardamom Aromatic· Tincture, B.P.C.

Aluminium Powder, B.P.C.	Catechu Tincture, B.P.C.
Amaranth Solution, A.P.F.	Cetyl Alcohol Compound.
Amaranth Solution, B.P.C.	Chloramine, B.P.C.
Amidopyrine, B.P.C. 1954.	Chloramphenicol Palmitatc, B.P.C.
Ammonia Aromatic Spirit, B.P.C.	Ch loramphcnicol Stearate.
Ammonia. Solution Strong, B.P.C.	Chloramphenicol Succinate.
Ammonia Solution Weak, B.P.C.	Ohlorazanil Hydrochloride.
Ammonium Bicarbonate, B.P.C.	Chforhcxidinc Diacctate.
Ammonium Bromide, B.P.C.	Chlorhcxidine Gluconate.
Amphotericin B.	Chloro'bcnzol Disulphonamide.
Ampicillin.	Chlorolrianisenc, B.P.C.
Antazaline Mcthanesulphonatc, B.P.C.	Chlorthalidone, B.P.C.
Antazoline Sulphate.	Choline Theophyllinatc, B.P.C.
Attapulgitc.	Cinnamon O'il, B.P.C.
Aurothiogliicose.	Clcmizolc Hydrochloride.
Bacitracin Eye Drops.	Clemizolc Tannate.
Beeswax, Yellow, B.P.C.	Clove, Concentrated Infusion, B.P.C.

Belladonna Suppository, B.P. 1948. 1954.

Benzalkonium Chloride.	CloxacHlin Sodium.
Bcnzocaine and Adrenaline Ointment,	Coal Tar, B.P.C.

A.P.F. Cochineal Tincture, B.P. 1948.

Benzoinatcd Lard, B.P.C. 1954.	Coconut Oil, B.P.C. 1949.
Benzoin Compound Tincture, B.P.C.	Codeine, B.P.C, 1954.
Benzoin Gum, B.P.C.	Colistin.
Benzoin Tincture, B.P.C.	Copper Sulphate, B.P.C.
Bonzol (Commercial).	Creosote, B.P.C. 1959.

Bcnzylpcnicillin in Oil. Cudbear Tincture, A.P.F. 1947.

Bephenium Hydroxynaphthoate, B.P.C.	Curd Soap, B.P.C.
Betamethasone.	Cyclopcnthiazidc.
Betamethasone Disodium Phosphate.	Cycl ctphosph amide.
Betamethasone Phosphate.	Cycriminc Hydrochloride.
Bismuth Glycollylarsanilate, B.P.C.	Cymogran.
Bismuth Sodium Tartrate, B.P.C.	Cyproheptadine Hydrochloride.
Bismuth Subgiallate, B.P.C.	Death Adler Antivcnenc.
Bretylium Tosylate.	Dcinccarium Bromide.
Brown Snake Antivencnc.	Deoxycortone Glucoside.
Buchu, Concentrated. Infusion, B.P.C.	Desfcrrioxaminc.

1954. Dcslanosidc.

Butabarbital Sodium.	Dcxamcthasonc Sodium Phosphate.
Butyl Aminobcnzoatc, B.P, 1953.	Dcxchloipheniraminc Malcate.
Cade Oil, B.P.C.	Dcxlran.
Caffeine and Sodium Benzoate, B.P.C.	Dcxtran Iron.

1954, Dcxtrifcrroti.

National Health (Pharmaceutical Benefits) Regulations. 10

Dicyclomine Hydrochloride B.P.C.	Ilydrargaphen.
Digitalis Tincture, B.P.C. 1959.	Hydrocyanic Acid, Dilute, B.P.C. 1954,
C'ihydrocrgotamjne Methanesulphonatc.	Ilydroxyprogesterone Caproate.
Dihydromorphinonc Hydrochloride, B.P.C.	llyosciuc Mctliobromidc.

1949 Hypo phosphorous Acid, Dilute, B.P.C,

Dihydrostreptomycin Sulphate, B.P. 1958.	Insulin Injection, specially purified.
Dihydrotachysterol.	Insulin Isophane Injection, specially puri­

Dill Oil, B.P.C. fied.

Dimcthicone, B.P.C.	Insulin Injection, Special P (Pig),
Diphenylpyraline Hydrochloride.	lodochlorhydroxyquinoline.
Dipyridamole.	Iodoform, B.P.C. 1954.
Disodium Dihydrogen Verscnatc.	Iron Aminoales.
Disodium Stilbocstrol Diphosphate.	Iron Oxide Saccharated.
Dithiazanine Iodide.	Iron Sorbitol Complex.
Dyflos, B.P.C.	Isoprenaline Hydrochloride.
Ecothiopate Iodide.	1'sopropamide Iodide.
Entsufon.	Isothipendyl Hydrochloride, B.P.C.
Ephcdrine, B.P.C.	Kanamycin Sulphate, B.P.C.
Ephedrine Sulphate, B.P.C. 1954.	Lanatosidc-C".
Ergot, Liquid Extract, B.P. 1914.	Lavender Spike Oil, B.P.C.
Erythromycin Ethyl Succinate.	Lemon Tincture, B.P. 1958.
Erythromycin Glucohcptonate.	Leptazol, B.P.C.
Erythromycin Lactobionatc.	I.issapol.
Erythromycin Stearate.	Lobelia Ethereal Tincture, B.P.C.
Et.hauolaminc, B.P.C,	Lofcnalac.
Ethanolamine Olcate.	Magenta, B.P.C.
Ether Nitrous Spirit, B.P.C. 1959.	Magnesium Bicarbonate Solution, B.P.

Ethionamide. 1948.

Ethosuximide.

Magnesium Chloride.

Ethoxzolamidc.

Magnesium Hydroxide, B.P.C.

Ethyl Biscoumacetate, B.P.C.

Magnesium Oxide, Heavy, B.P. 1958.

Ethylidene Dicoumarin.

Mcbhydrolin Napadisylatc, B.P.C.

Ethylnoradrcnaline Hydrochloride.

Mccholyl Chloride.

Eucalyptol, B.P.C.

Mcdroxyp rogesteronc Accta tc.

Extract of Ox Bile, B.P. 1948.

Mcrcaptomcrin Sodium

Ferric Hydroxide.

Mercuric Chloride, B.P.C.

Ferrous Aminoacetosulphate.

Mercuric Oxide E.yc Ointment, B.I’.C.

Mercurous Chloride Ointment, B.P. 1948.

Ferrous Carbonate SaccharatcJ, B.P.C.

Mercury Compound Ointment, B.P.C.

1959. 1959.

Ferrous Phosphate Compound Syrup, Mcstanolonc.

B.P.C. Metaraminol Bitartrate.

Ferrous Phosphate with Quinine and	Metformin Hydrochloride.
Strychnine Syrup, B.P.C. Ferrous Succinate.	Methandriol.
Mcthazolamidc.
Folinic Acid.	Methdilazinc Hydrochloride.
Framycetin Sulphate.	Methcnamine Mandelate.
Fusidic Acid, Diethanolamine Salt.	Methenolone Acetate.

Fusidic Acid, Sodium Salt.	Mcthcnolonc Ocnanthaie.
Galactomin.	Methotrexate.

Gall and Opium Ointment, B.P.C.	Mcthoxamine Hydrochloride, B.P.C.
Gclscmium Tincture, B.P.C.	Methyclothiazide.
Glucagon Hydrochloride.	Methyldopa.
Glucose Indicator.	Methyl Glticamiuc.

Glycerophosphate Compound S'yrup, Mcthylphenobarbitonc, B.P.C.

A.P.F. Metronidazole, B.P.C.

Gramicidin.	Minafen.
Haemophilus Influenza Bacterial Scrum,	Mitomycin.
Hamamclis Dry Extract, B.P.C’.	Myrrh Gum, Powdered, B.P.C,
Ilamamclis Liquid Extract, B.P.C.	Myrrh Tincture, B.P.C.
Heparin Retard.	Nandrolonc Dccanoalc,
Hexocyclium Mcthylsulphatc.	Niclosamide,
Honey, Purified, B.P.C.	Nicoumalone.

National Health (Pharmaceutical Benefits) Regulations. 11

Nitromin.	Rolitetracycline.
Nux Vomica, Dry Extract, R.P.C.	Rosemary Oil, B.P.C.
Oestradiol Dipropionatc, B.P.C. 1954.	Salicylamide.
Ocstrone, B.P.C. 1954.	Senega, Concentrated Infusion, B.P.C.
Oleandomycin.	Senna Compound Mixture, B.P.C, 1959.
Orange Peel Compound, Concentrated	Senna, Concentrated Infusion, B.P.C.

Infusion, B.P.C. 1954. Orange Peel, Concentrated Infusion, B.P.C. 1959.

Senna Fruit Extract (Standardised).

Orcipretialine Sulphate.	Siberian Fir Oil, B.P.C. 1949.
Ouabain, B.P. 1958.	Silver Picralc, B.P.C. 1949.
Oxymcl, B.P.C.	Silver Protein, B.P.C.
Oxymel of Squill, B.P.C.	Silver Protein Mild, B.P.C.
Oxymcstcrone.	Sobce.
Oxyphcncycliminc Hydrochloride.	Sodium Carbonate, B.P.C.
Oxyphenonium Bromide.	Sodium Carbonate Anhydrous, B.P.C.
Oxytocin.	Sodium Folate.
Pancreatin Enzyme, U.S.N.F. XI.	Sodium Lactate.
Papaverctum, B.P.C.	Sodium Nitrite, B.P.C.
Para-Aminosalicylic Acid.	Sodium Potassium Tartrate, B.P.C.
Paraben Ophthalmic Phosphate Buffer,	Sodium Tauroglycocholatc, B.P.C. 1954.
A. P.F. Paraben Ophthalmic Vehicle, A.P.F.	Sorbolcne, A.P.F.
Spearmint Oil, B.P.C.
Paraffin Liquid Light, B.P.C.	Spiramycin.
Paramethasonc Acetate.	Spironolactone, B.P.C.
Pectin.	Squill Tincture, B.P.C.
d-Penicillamine Hydrochloride, B.P.C.	Stanolone.
Penicillinase.	Stearic Acid, B.P.C.
Penicillin, Benpthamine, B.P.C.	Storax, Prepared, B.P.C.
Pentaerythritol Tetranitrale, diluted, B.P.C.	Strophanthus Tincture, B.P. 1948.
Pcnthicnatc Mcthobromidc.	Strychnine, B.P.C. 1959.

Pertussis Vaccine (1 lacmagglutinin Strychnine Hydrochloride, B.P.C.

Aluminium Phosphate Adsorbed). Peru Balsam, B.P.C.	Sulphacctamidc, B.P.C.
Sulphadiazinc Sodium, B.P.C.
Phenazone, B.P.C.	Sulphadimcthoxinc, B.P.C.
Phenazopyridinc Hydrochloride.	Sulphaguanidine, B.P.C.
Phcncthicillin Potassium.	Sulphamerazine, B.P. 1958.
Phenformin Hydrochloride.	Sulphamcthoxydiazine.
Phcniramine Maleatc.	Sulphamethoxypyridazine N-Acetyl.
Phcniramine Para-Aminosalicylate.	Sulphaphcnazolc, B.P.C.
Phenol Ointment, B.P. 1948.	Sulphapyridine, B.P.C. 1959.
Phcnoxymcthylpenicillin Benzathine.	Sulphasalazine.
Phenoxymcthylpenicillin, Ilydrabamiine.	Sulphathiazole, B.P.C.
Phcnsuximidc.	Sulphinpyrazonc, B.P.C.
Phcnytoin.	Sulphurated Potash, B.P.C.
Phthalylsulphacctamidc.	Sulphuric Acid, Dilute, B.P.C.
Physostigmine, B.P.C.	Sulphur Sublimed, B.P.C.
Pipenzolatc Mcthobromidc.	Sultiamc.

Pituitary	(Posterior	Lobe)	Powdered.	Surgical Cement.
B. P.C. Polythiazide.	Su station.

Syrup Glucose Liquid, B.P.C.

Potable Water.	Tacrine.
Potassium Acid Tartrate, B.P.C.	Taipan Antivenene.
Potassium Bicarbonate, B.P.C.	Tar Ointment, B.P.C. 1959.
Potassium Chlorate, B.P.C.	Tartrazmc, B.P.C. 1954.
Prcdnisolonc-Mcthyl Acetate.	Testosterone Oenanthate.
Prednisolone Sodium llemisuccinate.	Tetracycline.
Prednisolone Sodium Phosphate, B.P.C.	Thcnalidine.
Prednisolone Tertiary Butyl Acetate.	Thcnalidine Tartrate.
Protoveratrine A.	Theobromine, B.P.C.
Pyrazinamide.	Theobromine and Sodium Salicylate, B.P.

Pyridine Aldoximc Mcthiodidc. 1953.

Quillaia Tincture, B.P.C.	Theophylline Elixir.
Quincthazonc.	Thiotcpa.
Rauwolfia Alkaloids.	Thyrotrophin.
Red Back Spider Antivcncne.	Tiger Snake Antivcncne.
Ristocetin.	Tolu Tincture, B.P.C. 1959.

National Health (Pharmaceutical Benefits) Regulations. 12

Tragacanth (Gum Karaya).	Vadrine.
Tretamine.	Valerian Ammonialed Tincture, B.P.C.
Triamcinolone, B.P.C.	Vanillin, B.P.C.
Triamterene.	Vasopressin Tannale.
Triaziquone.	Vclactin.
Tvicyclamol Chloride.	Vinblastine Sulphate.
Triethanolamine, B.P.C.	Vinegar of Squill, B.P.C.
Triethanolamine Trinitrate.	Viomycin Pantothenate.
Trimeprazinc Tartrate, B.P.C.	Viprynium Binbonate.
Trinitrophenol, B.P.C. 1959.	Vitamin A.
Triprolidine Hydrochloride, B.P.C.	Vitamin D.
(Jroa, B.P.C.	Zinc Stearate, B.P.C.

FOURTH SCHEDULE.

Regulation 12.

A dditives.

Acetone, B.P.C.	Caraway Oil, B.P.C.
Alcohol (95%), B.P.	Carmine Solution, A.P.F.
Dilute Alcohols, B.P.	Citronclla Oil, B.P.C.
Amcthocainc Hydrochloride, B.P.	Cod Liver. Oil, B.P.
Bacitracin, B.P.	Xylene, B.P.C. 1949.

FIFTH SCHEDULE.

• Regulation 14.

P harmaceutical Ben efits the Prescribing of W hich is Su b ject to C onditions and

R estrictions.

Purpose for which, am! the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any

Pharmaceutical Benefits.	restrictions as to the persons for whose treatment it may
be prescribed) for supply under Part VII. of the Act.

Acetylsalicylic Acid Tablets, B.P. ..	Ί
Soluble Acetylsalicylic Acid Tablets,

B.P.

Compound Tablets, A.P.F. Acetylsalicylic Acid

ί-Any disease or condition in a pensioner

Compound Acetylsalicylic Add

Tablets, B.P.C. Soluble Compound Acetylsalicylic

Acid Tablets Acrylic Resin J

.. .. .. Ileostomy or colostomy conditions

Alkavervir	..	..	..	Hypertensive crises
Amphotericin	B	..	..	Systemic fungal infection
Ampicillin	..	.,	..	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Ampicillin is the only appropriate antibiotic

Ancurino Hydrochloride Tablets, Any disease or condition in a pensioner

B.P.

Ascorbic Acid Tablets, B.P.	..	Any disease or condition in a pensioner
Bemcgridc Injection, B.P.	..	As ail antidote to barbiturate and other hypnotic

poisons

Benzol (Commercial)	..	..	Ileostomy or colostomy conditions
Betamethasone Tablets ..	..	With the written authority of the Director-General a disease or condition specified in this column in relation to Prednisolone Tablets

National Health (Pharmaceutical Benefits) Regulations. 13

F ifth	Schedule—continued.
Purpose for which, and the Conditions subject to which, the

Pharmaceutical Benefit may be prescribed (including any

Pharmaceutical Benefits.	restrictions as to the persons for whose treatment it may
be prescribed) for supply under Part Vli. of the Act.

Busulphan Tablets, B .P ...

Leukaemia

Calciferol Tablets, B.P. ..

Any disease or condition in a pensioner.

With the written authority of the Director-General—

Hypoparathyroidism

Chronic hypoparathyroid tetany

Vitamin D-resistant rickets

Calciferol Solution, B.P. .. Any disease or condition in a child under the age of

twelve years or in a pensioner

Calcium Aminosalicylate .. Tuberculosis

Calcium Gluconogalacto-gluconate rfypoparathyroidism

Effervescent Tablets Caramiphen Tablets, B.P.	..	Parkinsonism
Chlorambucil Tablets, B.P.	..	Malignant lymphoma and related conditions
Chloramine Deodorant Tablets and	Ileostomy or colostomy conditions
Powder Chloramphenicol Capsules, B.P. .,	Bacillary dysentery that is resistant both to the

Sulphonamidcs and Streptomycin Sulphate

Bacterium coli meningitis, if other forms of treatment

are unsuccessful

Granuloma inguinale

Friedlander bacillus infections

Haemophilus influenza infections

Lymphogranuloma venereum

Salmonella infections

Staphylococcal infections

Typhoid fever

Typhus and other rickettsial diseases

Urinary tract infections due to gram negative bacilli

that are resistant to the Sulphonamides

Chloramphenicol Injections	..	\ A disease or condition specified in this column in
Chloramphenicol Tablets	..	f relation to Chloramphenicol Capsules

Chloramphenicol Oral Suspension A disease or condition specified in this column in relation to Chloramphenicol Capsules, in a child under the age of twelve years

Chlorotrianisene Tablets .. Carcinoma of the prostate twelve years

Chlorpheniramine Maleate Syrup

Any disease or condition in a child under the age of

Chlorpromazine Hydrochloride ..

Any disease or condition in a pensioner

Any disease or condition in a patient receiving treat­

ment in or at an approved hospital

With the written authority of the Director-General—■

Late-stage malignancy

Radiation sickness

With the written authority of the Director-General,

has been discharged from an approved hospital at the treatment of a mental disorder in a person who

which he received treatment for a mental disorder

and who is living in a place remote from an approved

hospital

The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlor­ promazine Hydrochloride, Trifluoperazine Hydro­ chloride or Thioridazine Hydrochloride

Chlortetracyclinc Capsules, B.P. .. As an alternative to the Penicillins in a person sensitive

to the Penicillins

Actinomycosis

Amocbiasis

National Health (Pharmaceutical Benefits) Regulations. 14

F ifth

Schedule—continued.

Purpose for which, and the Conditions subject to which, th

Pharmaceutical Benefit may be prescribed (including any

Pharmaceutical Benefits.	restrictions as to the persons for whose treatment it may
be prescribed) for supply under Part VII. of the Act.

Clilortctracycline Capsules, U P.— Bacterial endocarditis (Streptococcus faecalis), acute

continued. and sub-acute

Bacillary dysentery that is resistant both to the

Sulphonamides and Streptomycin Sulphate

Bronchiectasis

Brucellosis

Chancroid

Fibrocystic disease of the pancreas

Granuloma inguinale

Friedlander bacillus infections

Leptospirosis

Lymphogranuloma venereum

Muscoviscidosis

Pneumonia that is resistant both to the Penicillins

and the Sulphonamides Pre-operative prophylaxis Primary atypical pneumonia

Psittacosis

Puerperal infections

Rat-bite fever (Spirillum minus)

Staphylococcal infections

Trachoma that is resistant to the Sulphonamides

Typhus and other rickettsial diseases

Urinary tract infections due to gram negative bacilli

that are resistant to the Sulphonamides

Whooping cough (Haemophilus pertussis)

Chlortetracycline Hydrochloride Λ disease or condition, specified in this column in

Granules Choline Theophyllinate ..

relation to Chlortetracycline Capsules, in a child

under the age of twelve years

.. Any disease or condition in a patient receiving treat­

ment in or at an approved hospital

Clemizole Tannate Syrup .. Any disease or condition in a child under the age of

twelve years

Cloxacillin Sodium .. .. Any disease or condition in a patient receiving

treatment in or at an approved hospital

Compound Codeine Tablets, B.P...

Compound Codeine Soluble

Tablets, B.P. Codeine Phosphate with Acetyl-

salicylic Acid Soluble Tablets Codeine Phosphate with Acetyl-

salicylic Acid Tablets _Any disease or condition in a pensioner

Codeine Phosphate with Acetyl- salicylic Acid and Phenacetin Tablets

Codeine Phosphate with Acetyl- salicylic Acid, Phenacetin and Caffeine Tablets J .

Cod Liver Oil .. .. .. X Any disease or condition in a child under the age

Cod Liver Oil Emulsion .. / of twelve years or in a pensioner

Colistin .. .. .. Any disease or condition in a patient receiving

treatment in or at an approved hospital

Ί With the written authority of the Director-General—

Corticotropliin Injection, B.P.	..	I	A disease or condition specified in this column in
Corticotrophin Gelatin Injection,	|	relation to Cortisone Injection

B.P. '> I-Iypsarrhythmia

Corticotrophin Zinc Hydroxide I Salaam convulsions

Injection, B.P. The prevention of side effects of corticosteroid

J therapy

National Health (Pharmaceutical Benefits) Regulations. 15

F ifth	Schedule—continued.
Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any

Pharmaceutical Benefits.	restrictions as to the persons for whose treatment it may
be prescribed) for supply under Part VII. of the Act.

Cortisone Injection, B.P.

With the written authority of the Director-General—

Anaemia, acquired haemolytic

Addison’s disease or other forms of adrenocortical

hypoplasia

Adrenalectomy, total

Adrenogenital syndrome

Agranulocytosis

Behcet’s syndrome

Cranial arteritis

Cushing’s syndrome, including hyperadrenocorti-

calism

Dermatitis, acute exfoliative

Dcrmatomyositis

encephalomyelitis

encephalomyelitis, acute disseminated

Guillain-Barrd syndrome

Hamman-Rich syndrome—diffuse interstitial pul­

monary fibrosis Hansen’s disease Hepatitis, progressive or continuing, proven by

biopsy or biochemistry

Hodgkin’s disease

Idiopathic hypcrcalcacmia

Keratoplasty

Leucine-sensitive hypoglycaemia

Leukaemia

Lymphosarcoma and follicular lymphoma

Metastatic breast cancer

Nephrosis or nephrotic syndrome

Neuro-myelitis optica

Optic neuritis following removal of tumor of the

brain

Panhypopituitarism

Pemphigus

Periarteritis nodosa

Progressive transverse myelitis

Pseudohermaphroditism

Purpura, Henoch’s

Purpura, thrombocytopenic

Reticulum cell sarcoma

Rheumatic carditis, acute

Sarcoidosis

Scleroderma

Severe reactions of the skin and mucosa following

X-ray therapy

Splenic neutropenia Status asthmaticus Steroid therapy prior to operation in patients under

steroid therapy

Stevcns-Johnson syndrome

Still’s disease in a child under the age of sixteen

years

Sympathetic ophthalmitis

Systemic lupus erythematosus

Temporal arteritis

Tropical and non-tropical sprue and all forms of

mal-absorption associated with those diseases

Type II Nephritis

Ulcerative colitis proven by sigmoidoscopy or

radiological report

Uveitis, posterior

National Health (Pharmaceutical Benefits) Regulations. 16

F ifth	Schedule—continued.
Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any

Pharmaceutical Benefits.	restrictions as to the persons for whose treatment it may
be prescribed) for supply under Part VII. of the Act.

Cortisone Tablets, B.P. ..

With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection

Cyanocobalamin Injection, B.P.

(other than 1,C0) microgramme

strength)

Established megalocytic anaemia

Cyanocobalamin Injection, B.P. (1,000 microgramme strength)

Neuroblastoma

Subacute combined degeneration of the cord

Cymogran	..	..	..	With the written authority of the Director-General, phenylketonuria
Cycloserine, B.P.	..	..	\A n y disease or condition in a patient receiving

Cycloserine Capsules, B.P. .. / treatment in or at an approved hospital

Cyproheptadine Hydrochloride Sy­ Any disease or condition in a child under the age of

rup twelve years

Demethylchlortetracycline Capsules, A disease or condition specified in this column in

B.P. relation to Chlortetracycline Capsules

Demethylchlortetracycline Hydro­ chloride Oral Paediatric Drops Any disease or condition specified in this column in relation to Chlortetracycline Capsules, in a child

and Oral Suspension. . Deodorant Detergent Solution (Lts- . . under the age of twelve years

Ileostomy or colostomy conditions

sapol with Spearmint Oil and

Cetrimide)

Deoxycortone Aqueous Injections	Ί
Deoxycortone Acetate Injection, B.P.

Deoxycortone Trimethylacetate Addison's disease

Injection, B.P. Deoxycortone Acetate Implants, B.P.	Adrenalectomy, total
Deoxycortone Acetate Tablets	J ,

Desferrioxamine .. .. Any disease or condition in a patient receiving treatment in or at an approved hospital

Dexamethasone Tablets, B.P. .. With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets

Dexchlorphenirantine Maleate Any disease or condition in a child under the age of

Syrup twelve years

Dcxtran with Dextrose ..	..	1 Any disease or condition in a patient receiving
Dextran in Normal Saline	. .	f treatment in or at an approved hospital

Dicyclomine Hydrochloride Syrup Any disease or condition in a child under the age of

twelve years

Dienoestrol Cream	..	..	Any disease or condition in a pensioner
Dienoestrol Tablets, B.P.	..	Carcinoma of the prostate Mammary carcinoma Any disease or condition in a pensioner

Dihydrostrcptomycin Sulphate As an alternative to Streptomycin Sulphate in a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate

Injection

Dihydrotechysterol .. .. Parathyroid deficiency

Diiodohydroxyquinoline Vaginal, Trichomonal or mondial vaginitis

Tablet Diiodohydroxyquinoline Effervcs-	Trichomonal or mondial vaginitis
cent Gynaecological Pessary Diloxanide Furoate Tablets, B.P...	Amoebic dysentery

Dimethicone .. .. .. Ileostomy or colostomy conditions

Diphenhydramine Hydrochloride Any disease or condition in a child under the age of

Elixir twelve years

Disodium Stilboestrol Diphosphate Carcinoma of the prostate

Ditophal .. .. .. Any disease or condition in a patient receiving treat­ ment in or at an approved hospital

S '

National Health (Pharmaceutical Benefits) Regulations. 17

F ifth Schedule— continued.

Purpose for which, and the Conditions subject to which, the

Pharmaceutical Benefit may be prescribed (including any

Pharmaceutical Benefits.	restrictions as to the persons for whose treatment it may
be prescribed) for supply under Part VII. of the Act.

Ephedrine Hydrochloride with Any disease or condition in a child under the age of

Phenobarbitone Elixir twelve years

Erythromycin Capsules .. 1 A disease or condition specified in this column in

Erythromycin Tablets ..

Erythromycin Injections

j" relation to Chlortctracyclinc Capsules

Erythromycin, Oral Sachet

1 A disease or condition specified in this column in

Erythromycin, Oral Suspension

)- relation to Chlortetracyclinc Capsules in a child

J under the age of twelve years

Ethinyloestradiol Tablets, B.P.

Turner's syndrome

Pre-mcnopausal castration syndrome

Any disease or condition in a pensioner

Ethionamide .. . Any disease or condition in a patient receiving treat­ ment in or at an approved hospital

Ethisterone Tablets, B.P. Turner’s syndrome

Ethosuximide Syrup . Any disease or condition in a child under the age of twelve years

Ferric Hydroxide Colloidal Solution	Ί
Ferrous Aminoacetosulphate Syrup	| Any disease or condition in a child under the age of

Ferrous Gluconate Elixir	..	!-	twelve years
Ferrous Succinate Elixir	..
Ferrous Sulphate Oral Drops	..

Fludrocortisone Tablets, B.P.

Addison’s disease

Fluoxymesterone Tablets, B.P.

Mammary carcinoma

With the written authority of the Director-General,

long-term corticosteroid therapy

Folic Acid Injection	..	..	\ Macrocytic anaemia
Folic Acid Tablets, B.P.	..	J Sprue or the sprue-like syndrome

Folinic Acid .. .. ..

Fusidic Acid (Sodium Salt or Diethanolamine Salt)	[Any disease or condition in a patient receiving
j treatment in or at an approved hospital

Galactomin .. .. .. With the written authority of the Director-General, galactosaemia

Griseofulvin Tablets, B.P. .. With the written authority of the Director-General— For the treatment of any of the following diseases, the diagnosis of which has been confirmed by

pathological report—

Epidermophyton floccosum

Microsporum audouini

Microsporum canis

Microsporum gypseum

Trichophyton interdigitale

Trichophyton mentagrophytes

Trichophyton rubrum

Trichophyton schocnleini

Trichophyton sulplnireum

Trichophyton verrucosum

Halibut Liver Oil Capsules .. Any disease or condition in a pensioner

Haemophilus Influenza Bacterial

Serum

Hexachlorophane with Entsufon ..	!-Any disease or condition in a patient receiving
Hexachlorophane with Lissapol ..	| treatment in or at an approved hospital
Hexachlorophane in Soap Solution	J

Hydrocortisone Injection .. With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection

Hydrocortisone Sodium Succinate Acute adrenal failure due to medical or surgical

Injection crises

I Stevens-Johnson syndrome

National Health (Pharmaceutical Benefits) Regulations. 18

F ifth	Schedule—continued.
Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any

Pharmaceutical Benefits.	restrictions as to the persons for whose treatment it may
be prescribed) for supply under Part VII. of the Act.

Hydrocortisone Sodium Succinate Soluble Tablet With the written authority of the Director-General,

ulcerative colitis proven by sigmoidoscopy or

radiological report

Hydroxocobalamin Injection, B.P. (100 microgramme strength)	Established mcgalocytic anaemia
Hydroxocobalamin Injection, B.P. (1,000 microgramme strength)	Neuroblastoma
Sub-acute combined degeneration of the cord
Hydroxyprogesterone Caproate ..	Habitual abortion

Isoniazid Tablets, B.P.	..	..	Hansen’s disease Tuberculosis
Kanamycin Sulphate	..	..	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the only appropriate antibiotic
Levorphanol Tartrate	..	..	Obstetrical use Severe intractable pain

Liothyroninc Sodium .. . . \A n y disease or condition in a patient receiving

Liothyronine Tablets, B.P. .. / treatment in or at an approved hospital

Lofcnakc .. .. .. With the written authority of the Director-General,

phenylketonuria

Mebhydrolin Napadisylate Oral Any disease or condition in a child under the age of

Suspension Medroxyprogesterone Acetate twelve years

.. Any disease or condition in a patient receiving treatment in or at an approved hospital

Mepyramine Maleatc Elixir	..	Any disease or condition in a child under the age of twelve years
Mevcaptopurinc Tablets, B.P.	..	Allergic angiitis Leukaemia Lupus erythematosus Periarteritis
Mestanolone ..	Mammary carcinoma With the written authority of the Director-General,

long-term corticosteroid therapy

Mcthandicnone Tablets, B.P.

Mammary carcinoma

With the written authority of the Director-General,

long-term corticosteroid therapy

Methandriol ..

Senile osteoporosis proven by radiological report

With the written authority of the Director-General,

long-term corticosteroid therapy

Methdilazine Hydrochloride Syrup

Any disease or condition in a child under the age of twelve years

Methcnolone Acetate

Senile osteoporosis proven by radiological report

With the written authority of the Director-General,

long-term corticosteroid therapy

Methenolone Ocnanthate .. Any disease or condition in a patient receiving treat­ ment in or at an approved hospital

Mcthicillin Sodium	..	. .	\A ny disease or condition in a patient receiving
Mcthicillin Injection, B.P.	. .	/ treatment in or at an approved hospital

Methotrexate	..	..	..	Leukaemia and neo-plastic disease
Minafen	..	..	..	With the written authority of the Director-General, phenylketonuria
Mitomycin	..	..	..	Any disease or condition in a patient receiving treatment in or at an approved hospital

Morphine with Tacrine Tablets	..	Severe intractable pain
Mustine Injection, B.P. ..	..	Malignant lymphoma and related conditions

Nandrolonc Phenyl-propionate In­	1 Mammary carcinoma
jection B.P. Nandrolonc Dccanoate ..	J-With the written authority of the Director-General,

.. J long-term corticosteroid therapy

Neomycin Sulphate Tablets .. Any disease or condition in a patient receiving

treatment in or at an approved hospital

National· Health {Pharmaceutical Benefits) Regulations. 19

F ifth	Schedule—continued.
Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any

Pharmaceutical Ben efits.	restrictions as to the persons for whose treatment it may
be prescribed) for supply under Part VII. of the Act.

Nicotinamide Tablets .. Any disease or condition in a pensioner

Nicotinic Acid Tablets, B.P.	Any disease or condition in a pensioner
Nitrofurantoin Tablets, B.P.	Urinary tract infections
Nitrofurantoin Oral Suspension	Any urinary tract infection in a child under the age

of twelve years

Nitromin .. .. Malignant lymphoma and related conditions

Norethandrolone . . XAny disease or condition in a patient receiving

Noretbandrolonc Tablets, B.P. f treatment in or at an approved hospital

Novobiocin Calcium	..	1 Any disease or condition in a patient receiving
Novobiocin Sodium	..	j treatment in or at an approved hospital
Novobiocin Tablets, B.P.

Nystatin .. .. Proven monilia infections

Orciprenalinc Sulphate .. Any disease or condition in a patient receiving treatment in or at an approved hospital

Oxymcsterone .. .. Senile osteoporosis proven by radiological report With the written authority of the Director-General,

long-term corticosteroid therapy

Oxytctracyclino Hydrochloride

Capsules Oxytetracyclinc Tablets, B.P.. .	, A disease or condition specified in this column in
j" relation to Chlortetracycline Capsules

Oxytctracycline Hydrochloride

Injections Calcium di-Oxytctracyclinc Oral	J
) A disease or condition specified in this column in
Suspension Calciu m	1= relation to Chlortetracycline Capsules, in a child

di-Oxy tetracycline j under the age of twelve years

Paediatric Drops Oxytocin Nasal Spray ..	..	Induction of labour
j Fibrocystic disease

Pancrcatin B.P. .. .. j- Pancreatieo-duodencctomy

Pancrcatin Enzyme U.S.N.F. XI .. J Pancreatic steatorrhoca

Para-Aminosalicylic Acid	..	Tuberculosis
Paracetamol Oral Suspension	..	Any disease or condition in a child under the age of twelve years
Paramethasono Acetate ..	..	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Paraffin Liquid Emulsion	..	)

Paraffin Liquid Emulsion with J-Any disease or condition in a pensioner

Phenolphthalein J

Penicillamine .. .. ., With the written authority of the Director-General,

Wilson’s disease

Pethidine Hydrochloride with Obstetrical use

Levallorphan Tartrate Phenoxymethylpenicillin, Oral Ί

Suspensions Phenoxymethylpenicillin, l Any disease or condition in a child under the age

Oral f of twelve years

Sachets Benzylpenicillin with Streptomycin	j
1
Sulphate Benzylpenicillin	[Endocarditis due to Streptococcus faecalis or

with Procaine I Streptococcus viridans

Pencillin and Streptomycin

Sulphate Phenacetin with Codeine Phosphate J .

Any disease or condition in a pensioner

and Pentobarbitone Sodium Pheniraminc Malcate Syrup .. Any disease or condition in a child under the age of twelve years

Phenyloin .. .. .. Any disease or condition in a child under the age of twelve years

Phytomenadionc Injection, B.P. .. Antidote to anticoagulants

Piperazine Citrate Elixir.. .. Any disease or condition in a child under the age of twelve years

National Health (Pharmaceutical Benefits) Regulations. 20

F ifth	Schedule—continued.
Purpose for which, and the Conditions subject to which the
Pharmaceutical Benefit may be. prescribed (including any

Pharmaceutical Benefits.	restrictions as to the persons for whose treatment it may
be prescribed) for supply under Part ΥΓΓ. of the Act.

Pituitary, Posterior Lobe, insuffla­ Diabetes insipidus

tion

Prednisolone Sodium Phosphate Retention Enema

With the written authority of the Director-General,

ulcerative colitis proven by sigmoidoscopy or

radiological report

Prednisolone Tablets, B.P. .. With the written authority of the Director-General— Inflammatory conditions of the uveal tract and

retina

Nodular non-suppurative panniculitis (Christian-

Wcbcr disease)

A disease or condition specified in this column in relation to Cortisone Injection except Total adrenalectomy, Addison’s disease or other forms of adrenocortical hypoplasia

) With the written authority of the Director-General,

MethylprednisoloneTablets, B.P... > a disease or condition specified in this column in

Methylprednisolone Capsules . . J relation to Prednisolone Tablets

Prednisolone with Magnesium T ri­ silicate and Dried Aluminium With the written authority of the Director-General, a disease or condition specified in this column in

Hydroxide Gel relation to Prednisolone Tablets

Prednisolone Sodium Ilcmisuccinatc Any disease or condition in a patient receiving treat­ ment in or at an approved hospital

Prednisone Tablets, B.P. .. With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets

Prednisone with Magnesium Tri­ silicate and Dried Aluminium With the written authority of the Director-General, a disease or condition specified in this column in

Hydroxide Gel relation to Prednisolone Tablets

Progesterone .. .. .. Habitual abortion

Promethazine Hydrochloride Elixir Any disease or condition in a child under the age of twelve years.

Protoveratrine A .. . . Hypertensive crises

Pyrazinamidc .. .. . . Any disease or condition in a patient receiving treat­ ment in or at an approved hospital

Pyridine Aldoximc Methiodide. . Any disease or condition in a patient receiving treat­ ment in or at an approved hospital

Pyridostigmine Injection, B.P.	. .	Myasthenia gravis
Pyridostigmine Tablets, B.P.	. .	Myasthenia gravis
Pyridoxine Hydrochloride Tablets	Peripheral neuritis due to isoniazid therapy Radiation sickness

Quinethazonc ..	..	..	Any disease or condition in a patient receiving treatment in or at an approved hospital
Riboflavine Tablets	..	..	Any disease or condition in a pensioner

Ristocetin .. .. . . Any disease or condition in a patient receiving

treatment in or at an approved hospital

Senna Fruit Extract (Standardized) Any disease or condition in a pensioner

Sobee .. .. .. With the written authority of the Director-General— Galactosacmia Lactose intolerance Milk allergy

Sodium Aminosalicylate Tuberculosis

Sodium I'olalc . Macrocytic anaemia Sprue or the sprue-like syndrome

Spiramycin	..	.	Staphylococcal infections that are resistant both to the Tetracyclines and to tile Penicillins
Spironolactone	.	Any disease or condition in a patient receiving treatment in or at an approved hospital
Stanolonc	..	,	Mammary carcinoma With the written authority of the Director-General,

long-term corticosteroid therapy

National Health {Pharmaceutical Benefits) Regulations. 21

F ifth	Schbd.ulb—continued.
Purpose for which, and the Conditions subject to which, the

Pharmaceutical Benefit may be prescribed (including any

Pharmaceutical Benefits.	restrictions as to the persons for whose treatment it may
be prescribed) for supply under Part Vli. of the Act.

Ί Carcinoma of the prostate

Stilboestrol Injection	..	. .	> Mammary Carcinoma
Stilboestrol Tablets, B.P.	..	J Any disease or condition in a pensioner

Streptomycin Sulphate Injections. . Bacillary dysentery that is resistant to the

Sulphonamidcs

Brucellosis Chancroid Endocarditis due to Streptococcus faccalis or

Streptococcus viridans

Fricdlander bacillus infections

Haemophilus influenza infections

Plague

Pseudomonas pyocyanea infections

Rat-bite fever (Strcptobacillus moniliformis)

Salmonella infections

Surgical conditions of the bowel (pre-operative and

post-operative)

Surgical conditions of the thoracic organs

Tu bcrculosis

Tularaemia

Urinary tract infections that are resistant to the

Sulphonamidcs

Sulphadimethoxine Oral Suspen­

sion

S tlphadimidine Oral Suspension ..

Sulphamethoxydiazine Oral Sus­	Any disease or condition in a child under the age of
pension Sulphamethoxypyvidazine "N-Acetyl	* twelve years
Oral Suspension S tlphaphenazole Oral Suspension

Sulphasalazine .. .. .. Ulcerative colitis

Sultiame	..	..	..	For use where other anticonvulsants have failed
Surgical Cement	..	..	Ileostomy or colostomy conditions
Sustanon	..	..	..

Testosterone Implants, B.P.	..
Testosterone Oenanthate	.. Castration syndrome (male and female)

Testosterone Propionate Injection, )-Klinefelter Roifenstcin Albright syndrome

B.P. Mammary carcinoma

Testosterone Propionate Implants Methyltestosterone Tablets, B.P. .. Tetracycline Capsules, B.P. ..

Tetracycline Tablets, B.P. ..

Tetracycline Injections .. .. Tetracycline Hydrochloride, with a

buffering agent—Capsules and A disease or condition specified in this column in

Injection Tetracycline with Oleandomycin " relation to Chlortetracyclinc Capsules

Capsules and Injection Rolitctracycline	..	..
Tetracycline Granules	..	.. 1

Tetracycline Paediatric Drops	..
Tetracycline Oral Suspension	..

Tetracycline with a buffering

agent—Paediatric Drops Tetracycline with a buffering Λ disease or condition specified in this column in

agent—Oral Suspension Tetracycline with Oleandomycin	)■	relation to Chlortetracyclinc Capsules, in a child
under the ago of twelve years
Oral Sachet Tetracycline with Oleandomycin—
Oral Suspension Tetracycline with Oleandomycin

Paediatric Drops

«*

National Health (Pharmaceutical Benefits) Regulations. 22

F ifth	Schedule—continued.
Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any

Pharmaceutical Benefits.	restrictions as to the persons for whose treatment it may
be prescribed) for supply under Part VII. of the Act.

Tetracycline with a buffering agent and Amphotericin B

A disease or condition specified in this column in relation to Tetracycline with a buffering agent and Nystatin in a child under the age of twelve years

Tetracycline with a buffering agent and Nystatin

Broad spectrum antibiotic therapy of premature

infants, of patients under steroid therapy or of

cases complicated by intestinal moniliasis

A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracyclinc Capsules

Thenalidine Lactobionatc Syrup with Calcium Any disease or condition in a child under the age of twelve years

Theophylline Elixir .. .. Any disease or condition in a patient receiving treatment in or at an approved hospital

Thioridazine Tablets, B.P. .. Any disease or condition in a pensioner Any disease or condition in a patient receiving

treatment in or at an approved hospital

With the written authority of the Director-General—■

Late-stage malignancy

Radiation sickness

With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride or Thioridazine Hydrochloride

Thiotepa	..	..	XAny disease or condition in a patient receiving
Thyrotrophin	..	. .	j treatment in or at an approved hospital

Tragacanth (Gum Karaya) Ileostomy or colostomy conditions

Tretamine	..	..	Malignant lymphoma and related conditions
Triamcinolone	..	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets

Triamterene	..	..	..	\A n y disease or condition in a patient receiving
Triaziquone	..	..	..	J treatment in or at an approved hospital

Trifluoperazine Tablets, B.P. ..

Any disease or condition in a pensioner

Any disease or condition in a patient receiving treat­

ment in or at an approved hospital

With the written authority of the Director-General—■

Late-stage malignancy

Radiation sickness

With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride or Thioridazine Hydrochloride

t

National Health (Pharmaceutical Benefits) Regulations. 23

F ifth	Schedule—continued.
Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any

Pharmaceutical Benefits.	restrictions as to the persons for whose treatment it may
be prescribed) for supply under Part VII. of the Act,

Trimeprazinc Tartrate Syrup	..	Any disease or condition in a child under the age of twelve years
Trimetaphan Injection, B.P.	..	Hypotensive for anaesthesia
Triprolidinc Hydrochloride Elixir. .	Any disease or condition in a child under the age of twelve years

Vadrine .. .. .. \A n y disease or condition in a patient receiving Galactosacmia Lactose intolerance Milk allergy

Vancomycin Hydrochloride .. / treatment in or at an approved hospital

Vclactin .. .. .. With the written authority of the Director-General—■

Vinblastine Sulphate	..	..	Hodgkin’s disease
Viomycin Sulphate	..	..	\ Any disease or condition in a patient receiving

Viomycin Sulphate Injection B.P. .. / treatment in or at an approved hospital

Viomycin Sulphate with Viomycin Pantothenate Combination	Any disease or condition in a patient receiving treatment in or at an approved hospital
Vitamin Λ with Ancurine Hydro­ chloride, Riboflavine, Nicotin­ amide, Ascorbic Acid and Vitamin D	Any disease or condition in a pensioner

Vitamin A Tablets or Capsules	..	Any disease or condition in a pensioner
Concentrated Vitamin A Solution
Concentrated Vitamin A and D Solution	l Any disease or condition in a child under the age of
[ twelve years or in a pensioner
Concentrated Vitamin D Solution	Tetany Any disease or condition in a child under the age of

twelve years or in a pensioner

By Authority: A. J. A rthur, Commonwealth Government Printer, Canberra.